NaturalendoTech announced on March 24ththat thesafety of EstroG-100 was scientifically reconfirmed.

Naturalendo Tech has reconfirmed the safetyandefficacy of EstroG-100 on menopausal symptoms through the study complyingwiththe OECD guideline.

The researchers atChungnam National Universityhavereported that the results of in-vitro test showed that EstroG-100 doesnotactivate the estrogen receptors - The activation of the estrogen receptorshasbeen reported to cause breast cancer and endometrial cancer. As aresult,EstroG-100 has been proven to be safe in estrogen-related evaluations,and thestudy has been published in ‘Toxicological Research’.

Click the following to read : http://biz.newdaily.co.kr/news/article.html?no=10124312